1-20 of 29
Masaki Terabe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 682: Heterologous prime-boost viral vector vaccines for the treatment of a P1A-expressing BGL-1 glioblastoma model

Emily E. Steffke, James McAuliffe, Vinnycius Pereira Almeida, Amanda Wicki, Laurine Noblecourt, Gary Kohanbash, Hideho Okada, Carol Sze Ki Leung, Masaki Terabe, Benoit J. Van Den Eynde
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 682.
https://doi.org/10.1158/1538-7445.AM2023-682
Published: 04 April 2023
View article titled, Abstract 682: Heterologous prime-boost viral vector vaccines for the treatment of a P1A-expressing BGL-1 glioblastoma model
Journal Articles

Abstract 1015: Directionality of T-cell-mediated cross-protection against the same tumor in lungs versus skin

Jessica J. O'Konek, Elena Ambrosino, Anja Bloom, Liat Izhak, Jay A. Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1015.
https://doi.org/10.1158/1538-7445.AM2017-1015
Published: 01 July 2017
View article titled, Abstract 1015: Directionality of T-cell-mediated cross-protection against the same tumor in lungs versus skin
Journal Articles

Abstract 4622: Characterization of sulfatide reactive type II NKT cells from mouse lung

Lise Pasquet, Shingo Kato, Tony Adams, Susan Sharrow, Theresa Davies-Hill, Elaine Jaffe, Xia Zheng, Motoshi Suzuki, Damian Kovalovsky, Jay Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4622.
https://doi.org/10.1158/1538-7445.AM2017-4622
Published: 01 July 2017
View article titled, Abstract 4622: Characterization of sulfatide reactive type II NKT cells from mouse lung
Journal Articles

Abstract 58: Local intratumoral treatment with anti-mesothelin Immunotoxins overcomes resistance to anti-CTLA-4 therapy

Yasmin Leshem, Xiu-fen Liu, Tapan Bera, Masaki Terabe, Jay A. Berzofsky, Birgit Bossenmaier, Gerhard Niederfellner, James O'Brien, Yoram Reiter, Ira Pastan
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 58.
https://doi.org/10.1158/1538-7445.AM2017-58
Published: 01 July 2017
View article titled, Abstract 58: Local intratumoral treatment with anti-mesothelin Immunotoxins overcomes resistance to anti-CTLA-4 therapy
Journal Articles

Abstract 5660: Tumor cell death caused by INT230-6 induces protective T cell immunity

Anja C. Bloom, Lewis H. Bender, Ian B. Walters, Katharine T. Clark, Masaki Terabe, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5660.
https://doi.org/10.1158/1538-7445.AM2017-5660
Published: 01 July 2017
View article titled, Abstract 5660: Tumor cell death caused by INT230-6 induces protective T cell immunity
Journal Articles

Abstract 4007: A novel immunotherapy, INT230-6, is able to induce high rates of complete response in mice through a cytotoxic T-cell-dependent mechanism

Ian B. Walters, Anja C. Bloom, Lewis H. Bender, Masaki Terabe, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4007.
https://doi.org/10.1158/1538-7445.AM2016-4007
Published: 15 July 2016
View article titled, Abstract 4007: A novel immunotherapy, INT230-6, is able to induce high rates of complete response in mice through a cytotoxic T-cell-dependent mechanism
Journal Articles

Abstract 4295: INT230-6, a novel intratumoral anticancer agent, is able to eradicate large established tumors and stimulate potent anti tumor immunity

Ian B. Walters, Lewis H. Bender, Masaki Terabe, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4295.
https://doi.org/10.1158/1538-7445.AM2015-4295
Published: 01 August 2015
View article titled, Abstract 4295: INT230-6, a novel intratumoral anticancer agent, is able to eradicate large established tumors and stimulate potent anti tumor immunity
Journal Articles

Abstract LB-233: Blockade of TGF-beta1 and 2 without TGF-beta3 blockade is sufficient to facilitate tumor vaccine efficacy

Masaki Terabe, Faith Robertson, Shingo Kato, Emma De Ravin, Katharine Clark, Amer M. Mizra, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-233.
https://doi.org/10.1158/1538-7445.AM2015-LB-233
Published: 01 August 2015
View article titled, Abstract LB-233: Blockade of TGF-beta1 and 2 without TGF-beta3 blockade is sufficient to facilitate tumor vaccine efficacy
Journal Articles

CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy

David R. Soto-Pantoja, Masaki Terabe, Arunima Ghosh, Lisa A. Ridnour, William G. DeGraff, David A. Wink, Jay A. Berzofsky, David D. Roberts
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6771–6783.
https://doi.org/10.1158/0008-5472.CAN-14-0037-T
Published: 30 November 2014
View article titled, CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
Open the PDF for CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract 3657: Cross-regulation between the two subsets of NKT cells is dependent on interferon-gamma

Liat Izhak, Shingo Kato, Stanley T. Parish, Masaki Terabe, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3657.
https://doi.org/10.1158/1538-7445.AM2014-3657
Published: 01 October 2014
View article titled, Abstract 3657: Cross-regulation between the two subsets of NKT cells is dependent on interferon-gamma
Journal Articles

Abstract 460: Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

Liat Izhak, Elena Ambrosino, Jessica J. O'Konek, Shingo Kato, Stanley T. Parish, Zheng Xia, David Venzon, Jay A. Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 460.
https://doi.org/10.1158/1538-7445.AM2013-460
Published: 15 April 2013
View article titled, Abstract 460: Delicate balance among three types of T cells in concurrent regulation of tumor immunity.
Journal Articles

Abstract 4571: Autologous TARP peptide vaccination is associated with slowing in PSA velocity and a decrease in tumor growth rate in patients with Stage D0 prostate cancer.

Lauren V. Wood, William L. Dahut, Antonio Fojo, James L. Gulley, Ravi Madan, Philip Arlen, Howard L. Parnes, Brenda D. Roberson, Seth M. Steinberg, Masaki Terabe, Julia Wilkerson, Ira Pastan, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4571.
https://doi.org/10.1158/1538-7445.AM2013-4571
Published: 15 April 2013
View article titled, Abstract 4571: Autologous TARP peptide vaccination is associated with slowing in PSA velocity and a decrease in tumor growth rate in patients with Stage D0 prostate cancer.
Journal Articles

Abstract 1262: Identification of sulfatide reactive type II NKT cells using CD1d dimers.

Stanley Parish, Liat Izhak, Zheng Xia, Motoshi Suzuli, Masaki Terabe, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1262.
https://doi.org/10.1158/1538-7445.AM2013-1262
Published: 15 April 2013
View article titled, Abstract 1262: Identification of sulfatide reactive type II NKT cells using CD1d dimers.
Journal Articles

Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity

Liat Izhak, Elena Ambrosino, Shingo Kato, Stanley T. Parish, Jessica J. O'Konek, Hannah Weber, Zheng Xia, David Venzon, Jay A. Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2013) 73 (5): 1514–1523.
https://doi.org/10.1158/0008-5472.CAN-12-2567
Published: 03 March 2013
View article titled, Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity
Open the PDF for Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity in another window
Journal Articles

Abstract 1556: α-mannosylceramide, a new NKT cell agonist, induces tumor immunity without anergy induction in NKT cells

Jessica O'Konek, Satomi Takao, Liat Izhak, Petr Illarinov, Gurdyal Besra, Jay Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1556.
https://doi.org/10.1158/1538-7445.AM2012-1556
Published: 15 April 2012
View article titled, Abstract 1556: α-mannosylceramide, a new NKT cell agonist, induces tumor immunity without anergy induction in NKT cells
Journal Articles

Abstract 4746: Type I NKT cells mediate anti-tumor immunity through a TNF-α- and NOS-dependent pathway when stimulated with β-ManCer

Jessica J. O'Konek, Petr Illarinov, Deborah Stewart Khursigara, Elena Ambrosino, Liat Izhak, Bernard F. Castillo, Ravinder Raju, Maryam Khalili, Hee-Yong Kim, Amy Howell, Gurdyal S. Besra, Steven A. Porcelli, Jay A. Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4746.
https://doi.org/10.1158/1538-7445.AM2011-4746
Published: 15 April 2011
View article titled, Abstract 4746: Type I NKT cells mediate anti-tumor immunity through a TNF-α- and NOS-dependent pathway when stimulated with β-ManCer
Journal Articles

Abstract 5520: Therapeutic vaccination with epitope-enhanced and wild-type TARP peptides in stage D0 prostate cancer

Lauren V. Wood, William Dahut, James L. Gulley, Ravi A. Madan, Philip Arlen, Howard L. Parnes, Brenda D. Roberson, Seth M. Steinberg, Masaki Terabe, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5520.
https://doi.org/10.1158/1538-7445.AM2011-5520
Published: 15 April 2011
View article titled, Abstract 5520: Therapeutic vaccination with epitope-enhanced and wild-type TARP peptides in stage D0 prostate cancer
Journal Articles

Abstract 5613: Beta-mannosylceramide: a novel NKT cell agonist which synergizes with alpha-galactocylceramide to induce protection against tumors

Jessica J. O'Konek, Petr Illarionov, Deborah Stewart Khursigara, Elena Ambrosino, Bernard F. Castillo, Ravinder Raju, Maryam Khalili, Hee-Yong Kim, Amy R. Howell, Gurdyal S. Besra, Steven A. Porcelli, Jay A. Berzofsky, Masaki Terabe
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5613.
https://doi.org/10.1158/1538-7445.AM10-5613
Published: 15 April 2010
View article titled, Abstract 5613: Beta-mannosylceramide: a novel NKT cell agonist which synergizes with alpha-galactocylceramide to induce protection against tumors
Journal Articles

An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments

Jeong-Seok Nam, Masaki Terabe, Mizuko Mamura, Mi-Jin Kang, Helen Chae, Christina Stuelten, Ethan Kohn, Binwu Tang, Helen Sabzevari, Miriam R. Anver, Scott Lawrence, David Danielpour, Scott Lonning, Jay A. Berzofsky, Lalage M. Wakefield
Journal: Cancer Research
Cancer Res (2008) 68 (10): 3835–3843.
https://doi.org/10.1158/0008-5472.CAN-08-0215
Published: 15 May 2008
View article titled, An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
Open the PDF for An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments in another window
Includes: Supplementary data
Journal Articles

Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17

Jeong-Seok Nam, Masaki Terabe, Mi-Jin Kang, Helen Chae, Nga Voong, Yu-an Yang, Arian Laurence, Aleksandra Michalowska, Mizuko Mamura, Scott Lonning, Jay A. Berzofsky, Lalage M. Wakefield
Journal: Cancer Research
Cancer Res (2008) 68 (10): 3915–3923.
https://doi.org/10.1158/0008-5472.CAN-08-0206
Published: 15 May 2008
View article titled, Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17
Open the PDF for Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17 in another window
Includes: Supplementary data